A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women
A Randomized, Controlled, Double-Blind, Cross-Over Trial of Safety, Effect on Genital Tract HIV Shedding, and Acceptability of Vaginal Use of Carraguard by HIV-Infected Women
Sponsor: Centers for Disease Control and Prevention
Listed as NCT00213044, this PHASE1 trial focuses on HIV Infections and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 7 times since 2003, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 2 earlier versions
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Sep 2017 [monthly]
Completed PHASE1
First recorded
Mar 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- Chiang Rai District Health Office
- Chiang Rai Hospital
- Chiang Rai Municipal Health Office
- Chiang Rai Public Health Office
- Ministry of Health, Thailand
- National Center for HIV STD and TB Prevention
- National Center for Infectious Diseases
- Population Council
For direct contact, visit the study record on ClinicalTrials.gov .